MEDICAMENTS

Plus

    UK – NICE issues final draft guidelines for Novartis’ Kymriah

    The decision paves the way for young people with relapsed or refractory B-cell acute lymphoblastic leukaemia (ALL) to access Novartis’ Kymriah (tisagenlecleucel) through the...

    DISPOSITIFS MEDICAUX

    Plus

      COSMETIQUES

      Plus

        SANTE PUBLIQUE

        Plus

          INSCRIVEZ-VOUS A NOTRE NEWSLETTER

          NOS PROCHAINES FORMATIONS